Arrowhead Pharma Balance Sheet - Annual (NASDAQ:ARWR)

Add to My Stocks
$18.88 $0.3 (1.61%) ARWR stock closing price Sep 20, 2018 (Closing)

The Arrowhead Pharma balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Financial strength can be guaged by performing Arrowhead Pharma stock analysis and by analyzing the balance sheet. A company releases its balance sheet every year along with its annual results. Arrowhead Pharma had a long term debt of $2.32M at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Arrowhead Pharma operating cash flow and Arrowhead Pharma revenue also. Arrowhead Pharma debt to equity ratio is 0.02.

View latest 10 year balance sheet data to check Arrowhead Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep2017201620152014201320122011201020092008
Cash24.83M85.36M81.21M132.51M19.11M3.37M7.5M6.84M2.02M10.09M
Marketable Securities40.76M-17.53M21.65M9.03M-----
Receivables------1.6M---
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable-----2.44M----
Other Current Assets2.22M5.06M4.11M-------
Total Current Assets
67.9M90.5M102.87M154.8M28.84M6.56M9.86M8.13M2.48M10.56M
Property Plant & Equipment22.6M19.89M9.98M8.06M6.59M6.46M-1.31M1.55M2.84M
Accumulated Depreciation7.08M4.51M5.46M4.19M3.08M1.56M-1.17M1.02M1.59M
Net Property Plant & Equipment
15.51M15.38M4.52M3.87M3.51M4.89M---1.24M
Investment & Advances---23.08M--1.83M1.99M2.21M2.44M
Other Non-Current Assets------2.27M---
Deferred Charges----------
Intangibles20.46M22.16M24.82M1.01M3.24M4.78M1.73M2.04M2.36M2.74M
Deposits & Other Assets----1.73M-----
Total Assets
104.02M128.17M132.26M182.81M37.32M16.52M15.88M12.35M7.7M17.25M
Notes Payable----------
Accounts Payable4.07M12.23M5.03M2.57M1.19M---1.01M1.34M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses7.96M8.55M9.2M4.66M1.54M1.85M1.06M--1.09M
Income Taxes Payable----------
Other Current Liabilities6.45M4.65M1.45M4.33M4.78M2.37M-2.59M--
Total Current Liabilities
18.7M25.64M15.9M11.84M8.72M5.32M2.58M4.27M2.34M3.72M
Mortgages----------
Deferred Taxes/Income1.92M4.77M--------
Convertible Debt----------
Long-Term Debt2.32M2.53M--------
Non-Current Capital Leases----1.06M1.28M----
Other Long-Term Liabilities--6.2M4.22M1.75M-----
Total Liabilities
23.15M33.15M22.64M16.83M11.59M7.71M3.32M4.27M2.84M4.95M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus514.03M493.84M426.87M391.16M193.51M145.91M127.47M119.71M110.07M97.75M
Retained Earnings-432.81M-398.43M-316.71M-224.77M-166.14M-134.99M-113.87M-110.74M-104.96M-85.49M
Treasury Stock----------
Other Liabilities-0.52M-0.54M-0.69M-0.55M-1.76M-2.21M-1.12M-0.96M-0.3M-
Shareholders Equity80.86M95.02M109.62M165.98M25.73M8.8M12.56M8.07M4.85M12.3M
Total Liabilities & Shareholders Equity104.02M128.17M132.26M182.81M37.32M16.52M15.88M12.35M7.7M17.25M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Arrowhead Pharma stock price, and Arrowhead Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Arrowhead Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the Arrowhead Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Arrowhead Pharma had total assets of $104.02M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ARWR stock had total liabilities of $23.15M for the year 2017.

Arrowhead Pharma Balance Sheet - Key Ratios

Current ratio
8.68
Debt to equity ratio
0.02
Asset turnover ratio
0.02
Receivables turnover
59.13
Price to book ratio
18.14